amylyx glp-1 Pivots to Space, Acquires Phase III-Ready Asset from Eiger Amylyx Pharmaceuticals Acquires Phase III-Ready
Description
When activated, these receptors appear to dampen the dopamine-driven reward response that makes alcohol feel pleasurable and reinforcing effectively quieting the neurological "pull" toward drinking
| 122 comments on LinkedIn
Could GLP-1 drugs be used to fight Alzheimer's disease
GLP-1 plays a crucial role in regulating blood sugar levels by stimulating insulin secretion
Listen now (47 mins) |
Jean Paul Lim, MD, FRCPC, Medical Director, Ageless Living
